IGF1 and stroke disorder: To identify neuroprotective miRNAs, we used an alternate strategy by interrogating the 3′ UTR of a known neuroprotectant, Insulin-like Growth Factor (IGF)-1, for specific miRNA target sites, with the goal of inhibiting these miRNA to elevate local levels of IGF-1 post-stroke.